Navigation Links
Danaher Reports Record Fourth Quarter 2012 Results
Date:1/29/2013

ing the items identified in the reconciliation schedule above.  This non-GAAP measure should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

Management believes that this measure provides useful information to investors by reflecting additional ways of viewing aspects of Danaher's operations that, when reconciled to the corresponding GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.  The items described above have been excluded from this measure because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher's commercial performance during the period and/or we believe are not indicative of Danaher's ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.  The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company's larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.

The Company estimates the tax effect of the items identified in the reconciliation schedule above by applying the Company's overall estimated effective tax rate to the pre-tax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.

Core Revenue and Core Revenue GrowthWe use the term "core revenue" or "sales from existing b
'/>"/>

SOURCE Danaher Corporation
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Encision Reports 10% Product Revenue Increase in Third Quarter of Fiscal Year 2013 Results
2. Education and Collaboration Key to Continued Progress in Fighting Rogue Online Prescription Drug Sellers, Reports NABP
3. Uroplasty Reports Fiscal Third Quarter 2013 Financial Results
4. Cepheid Reports Fourth Quarter And Full Year 2012 Results
5. Covance Reports Fourth Quarter Pro Forma Net Revenue Of $561 Million, Pro Forma EPS Of $0.73 And Adjusted Net Orders Of $769 Million
6. Hill-Rom Reports Fiscal First Quarter Results; Updates 2013 Financial Outlook For R&D Tax Credit Reinstatement
7. Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2013
8. MGC Diagnostics Corporation Reports Fourth Quarter and Fiscal Year 2012 Operating Results
9. Avanir Pharmaceuticals Reports Fiscal 2012 Fourth Quarter And Year-End Financial And Business Results
10. Landauer, Inc. Reports Fiscal 2012 Fourth Quarter And Year End Results
11. Isis Pharmaceuticals Reports Positive Phase 1 Data On Three Drugs In Development To Treat Metabolic Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... , May 19, 2013  The non-surgical ... temperature radiofrequency (RF) energy is effective in control ... reduces the need for medication 10 years post-procedure, ... today at the Digestive Disease Week (DDW) meeting ... . "The sustained improvement ...
(Date:5/18/2013)... NEW YORK , May 18, 2013 /PRNewswire/ ... securities law firm, is investigating potential securities fraud ... (NASDAQ: AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ... the Company and its executives violated federal securities ... regarding the Company,s Phase III drug trials for ...
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. (NASDAQ: ... protective clothing for industry, healthcare and to first responders ... its financial results for the fiscal 2013 fourth quarter ... 21, 2013 at stock market close and will conduct ... p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ) ...
Breaking Medicine Technology:Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 2Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy 3Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2
...  theVisualMD, www.thevisualmd.com , the world,s leading health visualization resource ... Visual Rules of Wellness. Quest Diagnostics (NYSE: DGX ... services, is the official sponsor of the initiative,s first rule ... of Wellness aim to bring readers a new understanding of ...
... 3, 2012   GP Strategies Corporation (NYSE: ... of sales and technical training, e-Learning solutions, management consulting ... L.P. ("Sagard Capital") has agreed to purchase 350,000 shares ... The closing of the transaction is subject to customary ...
Cached Medicine Technology:theVisualMD Launches a Revolutionary New Visual Path to Wellness 2theVisualMD Launches a Revolutionary New Visual Path to Wellness 3theVisualMD Launches a Revolutionary New Visual Path to Wellness 4Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 2Sagard Capital Increases Ownership in GP Strategies by 350,000 Shares in a Private Transaction with Bedford Oak Partners, L.P. 3
(Date:5/20/2013)... Ponte Vedra Beach, Florida (PRWEB) May 20, 2013 ... healthcare value and market access, is pleased to present ... the Health Outcomes community. HE-Xpo vastly expands the ... utilizing an intuitive, web-based platform with the look, feel, ... to the global community of pharmaceutical professionals twenty-four hours ...
(Date:5/20/2013)... improved health care and significant reductions in drug costs ... between physicians and drug company representatives who promote the ... This system, which has been in place for decades, ... to date on new medications, and always provided generous ... the newest drugs, as well as other supplies and ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 WEDI, the ... improve the exchange of healthcare information, announced today at ... of the WEDI ICD-10 State Collaborative Initiative. The new ... members in order to increase efficiencies and reduce the ... The goal of the new initiative is to help ...
(Date:5/20/2013)... 2013 VHA Inc., the national ... automated, provider-led population health improvement, announced a new ... and successfully pursue population health management with ... to accelerate the transition to value-based models of ... improvement suite of services, the offering integrates VHA ...
(Date:5/20/2013)... May 20, 2013 The Multiple System ... the launch of its new Multiple System Atrophy ... few years, The MSA Coalition’s grass roots fundraising has ... mission beyond patient/caregiver support to now include education, advocacy ... all donations received by The Coalition go directly into ...
Breaking Medicine News(10 mins):Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 2Health News:HealthEconomics.Com Launches HE-Xpo, an Online Virtual Trade Show, Educational Center and Exhibit Hall at Major Pharmaceutical Industry Meeting 3Health News:Breakup of physician, drug company relationship could improve health care, cut cost 2Health News:Breakup of physician, drug company relationship could improve health care, cut cost 3Health News:WEDI Launches New ICD-10 State Collaborative Initiative to Increase Efficiencies and Reduce Compliance Time and Costs 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 2Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 3Health News:VHA Partners with Phytel to Add Population Health Management Services to the VHA IMPERATIVTM Performance Improvement Suite of Offerings 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 2Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 3Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 4Health News:Multiple System Atrophy (MSA) Research Grant Program Announced 5
... Kids treated more than 150 days after an Anterior Cruciate ... including medial meniscal tears, say researchers presenting at the American ... Francisco, CA. "In our research, children who had delayed ... to have an increased chance of also having a medial ...
... FRANCISCO, CA When it comes to treating people ... with the use of magnetic resonance images (MRI), according ... Society for Sports Medicine,s (AOSSM) Specialty Day in San ... sample of volunteers without any hip pain, and discovered ...
... appeared to not affect injury rates and performance in ... Orthopaedic Society for Sports Medicine,s Specialty Day in San ... an injury and enhanced performance in baseball pitchers is ... Carl W. Nissen, MD of Elite Sports Medicine and ...
... (HealthDay News) -- ,There,s little evidence linking disease severity ... in HIV-positive children and teens infected around the time ... experts were concerned that more severe HIV illness -- ... specific highly active antiretroviral therapy regimens might increase the ...
... By Steven Reinberg HealthDay Reporter , FRIDAY, Feb. ... ago that a strange new strain of flu first appeared ... States and eventually much of the globe. The H1N1 ... it proved particularly dangerous to children and younger adults -- ...
... Dentistry at the University of Alberta is hoping its latest ... that target certain types of cancers. , The discovery ... fellow Nicolas Coquelle has shed light on what happens in ... a DNA repair enzyme called polynucleotide kinase/phosphatase, or PNKP. This ...
Cached Medicine News:Health News:Delaying ACL reconstruction in kids may lead to higher rates of associated knee injuries 2Health News:HIV Severity, Treatment Unrelated to Kids' Mental Woes: Study 2Health News:H1N1 'Swine' Flu Makes a Comeback in Mexico 2Health News:New understanding of DNA repair could eventually lead to cancer therapy 2
... is an automated microplate analyzer ... microplate techniques. Open architecture design ... many manufacturers' microplate assays and ... R.I.A. and I.F.A. methods as ...
... MAP D-Type can combine a number ... 180 microplates on a simple to ... instrument is a multifunctional stand-alone device ... larger robotic systems. Custom and standard ...
... provides a fast, accurate assessment of,patient ... patented,state-of-the-art optics yield accurate measurements of ... total hemoglobin. When,used in combination with ... gives a comprehensive and complete assessment ...
The Stat Profile pHOx CO-Oximeter is intended for use in those situations where a more comprehensive profile beyond the measured hematocrit, hemoglobin, and SO2% offered by the Stat Profile pHOx ...
Medicine Products: